Schoenfeld D, Zhou R, Zairis S, Su W, Steinbach N, Mathur D, et al. Loss of PBRM1 alters promoter histone modifications and activates ALDH1A1 to drive renal cell carcinoma. Mol Cancer Res. 2022;: pubmed publisher

Voronkova M, Rojanasakul L, Kiratipaiboon C, Rojanasakul Y. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer. Mol Cell Biol. 2020;40: pubmed publisher

Solomon H, Dinowitz N, Pateras I, Cooks T, Shetzer Y, Molchadsky A, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. 2018;37:1669-1684 pubmed publisher

Gasparetto M, Pei S, Minhajuddin M, Khan N, Pollyea D, Myers J, et al. Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1. Haematologica. 2017;102:1054-1065 pubmed publisher

Wang J, Nikhil K, Viccaro K, Chang L, White J, Shah K. Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer. BMC Biol. 2017;15:10 pubmed publisher